inside - Susan G. Komen
... years, there is still much work to be done. For instance, there are still women living in the United States who do not have access to annual screening mammography. We promise to continue to work to ensure that every willing woman over the age of 40 receives a yearly mammogram and is educated about t ...
... years, there is still much work to be done. For instance, there are still women living in the United States who do not have access to annual screening mammography. We promise to continue to work to ensure that every willing woman over the age of 40 receives a yearly mammogram and is educated about t ...
to the booklet
... A total of over 1,400 before and after faceto-face interviews were carried out. Key findings were: • 40% have seen, read or heard something from the campaign • 70% of people more confident of noticing cancer symptoms • 75% stated that the campaign has made them more likely to visit their GP if th ...
... A total of over 1,400 before and after faceto-face interviews were carried out. Key findings were: • 40% have seen, read or heard something from the campaign • 70% of people more confident of noticing cancer symptoms • 75% stated that the campaign has made them more likely to visit their GP if th ...
A Review of Breast Cancer Research in Malaysia
... Four hundred and nineteen articles related to breast cancer were found in a search through a database dedicated to indexing all original data relevant to medicine published in Malaysia between the years 2000-2013. One hundred and fifty four articles were selected and reviewed on the basis of clinica ...
... Four hundred and nineteen articles related to breast cancer were found in a search through a database dedicated to indexing all original data relevant to medicine published in Malaysia between the years 2000-2013. One hundred and fifty four articles were selected and reviewed on the basis of clinica ...
Role of GPs in breast cancer- related arm morbidity care
... responsibility for the management of women’s treatment-related arm morbidity needs. Using a qualitative research method, the authors spoke to general practitioners (GPs) about their perceptions, knowledge and experiences of breast cancer-related arm morbidity, and what role, if any, they thought the ...
... responsibility for the management of women’s treatment-related arm morbidity needs. Using a qualitative research method, the authors spoke to general practitioners (GPs) about their perceptions, knowledge and experiences of breast cancer-related arm morbidity, and what role, if any, they thought the ...
Breast Related Procedures
... mastectomy for breast cancer is a covered benefit and addressed in II. C. above. Treatment for gynecomastia, the excessive growth of the male mammary glands, is addressed in II. E. above. C. Breast Reconstruction and Revision Breast reconstruction surgery includes those surgical procedures which are ...
... mastectomy for breast cancer is a covered benefit and addressed in II. C. above. Treatment for gynecomastia, the excessive growth of the male mammary glands, is addressed in II. E. above. C. Breast Reconstruction and Revision Breast reconstruction surgery includes those surgical procedures which are ...
Treatment of MBC – Subtypes and Perspectives
... therapy for patients with MBC and positive HRs. Patients with soft tissue and bone metastases are more likely to have ER positive tumors [19] and better response to HT than those with visceral metastases [20]. In addition to strategies followed in Luminal A patients, high grade Luminal B patients ma ...
... therapy for patients with MBC and positive HRs. Patients with soft tissue and bone metastases are more likely to have ER positive tumors [19] and better response to HT than those with visceral metastases [20]. In addition to strategies followed in Luminal A patients, high grade Luminal B patients ma ...
BRCA1 and BRCA2 mutation predictions using the BOADICEA and
... populations has not been evaluated. We used data from FrenchCanadian families to evaluate the mutation predictions given by the BRCAPRO and BOADICEA models. We also used this data set to estimate the age-specific risks for breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Methods A tot ...
... populations has not been evaluated. We used data from FrenchCanadian families to evaluate the mutation predictions given by the BRCAPRO and BOADICEA models. We also used this data set to estimate the age-specific risks for breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Methods A tot ...
Breast Cancer in Young Women in Canada
... treatments, as well as in discussing their research and treatment options with their doctors. Many women surveyed relied on web-based research and advice from other women who had undergone treatment. Young women surveyed tended to have chemotherapy recommended more often than older women (82% vs. 65 ...
... treatments, as well as in discussing their research and treatment options with their doctors. Many women surveyed relied on web-based research and advice from other women who had undergone treatment. Young women surveyed tended to have chemotherapy recommended more often than older women (82% vs. 65 ...
Issue 1 - Society of Breast Imaging
... atlas that is the model for liver, lung, prostate, and thyroid cancer screening atlases in development. Current members revise the atlas and accredit clinical sites throughout the country. They journey to other nations to guide developing screening programs around the world. They are asking the next ...
... atlas that is the model for liver, lung, prostate, and thyroid cancer screening atlases in development. Current members revise the atlas and accredit clinical sites throughout the country. They journey to other nations to guide developing screening programs around the world. They are asking the next ...
Breast Cancer - Baxter Healthcare
... to some other cause. Your doctor may ask about your personal and family medical history. You may have a physical exam. Your doctor also may order a mammogram or other imaging procedure. These tests make pictures of tissues inside the breast. After the tests, your doctor may decide no other exams are ...
... to some other cause. Your doctor may ask about your personal and family medical history. You may have a physical exam. Your doctor also may order a mammogram or other imaging procedure. These tests make pictures of tissues inside the breast. After the tests, your doctor may decide no other exams are ...
ASPS Consent - Crescent View Surgery Center
... Every surgical procedure involves a certain amount of risk and it is important that you understand these risks and the possible complications or adverse events associated with them. In addition, every procedure has limitations in terms of the outcome that patients will achieve afterwards. Additional ...
... Every surgical procedure involves a certain amount of risk and it is important that you understand these risks and the possible complications or adverse events associated with them. In addition, every procedure has limitations in terms of the outcome that patients will achieve afterwards. Additional ...
Bisphosphonates for advanced breast cancer
... identified the need to review the evidence and update information about bisphosphonates for women with advanced breast cancer following consultation with a range of stakeholders and advisors. A Cochrane review was first published in 2005,1 with evidence updated until 2007, that assessed the effect o ...
... identified the need to review the evidence and update information about bisphosphonates for women with advanced breast cancer following consultation with a range of stakeholders and advisors. A Cochrane review was first published in 2005,1 with evidence updated until 2007, that assessed the effect o ...
Secondary. Not second rate.
... There is no accurate, up-to-date figure on the number of people diagnosed or living with secondary breast cancer in the UK. In January 2013, it was mandated for data on secondary breast cancer to be collected by NHS Hospital Trusts in England1. However, to date, no such figures have been published. ...
... There is no accurate, up-to-date figure on the number of people diagnosed or living with secondary breast cancer in the UK. In January 2013, it was mandated for data on secondary breast cancer to be collected by NHS Hospital Trusts in England1. However, to date, no such figures have been published. ...
Women`s awareness of cancer symptoms: a
... Web of Knowledge, Health Reference Centre, Informit and PsycINFO were searched using the following keywords: ‘cancer’ AND ‘knowledge’ OR ‘awareness’ OR ‘understanding’ AND ‘symptoms’ AND ‘women’. An additional search using the keywords ‘cancer’ AND ‘help-seeking’ OR ‘delay’ was also conducted. Liter ...
... Web of Knowledge, Health Reference Centre, Informit and PsycINFO were searched using the following keywords: ‘cancer’ AND ‘knowledge’ OR ‘awareness’ OR ‘understanding’ AND ‘symptoms’ AND ‘women’. An additional search using the keywords ‘cancer’ AND ‘help-seeking’ OR ‘delay’ was also conducted. Liter ...
AGE IS JUST A NUMBER The report of the parliamentary inquiry
... Public Health England should support on-going evaluation of the campaign and, if appropriate, secure funding for national roll out. The Promoting Early Presentation (PEP) intervention targets older women at their final breast screening appointment to inform them about their continued breast cancer r ...
... Public Health England should support on-going evaluation of the campaign and, if appropriate, secure funding for national roll out. The Promoting Early Presentation (PEP) intervention targets older women at their final breast screening appointment to inform them about their continued breast cancer r ...
awareness of breast cancer risk factors and early detection
... second cause of cancer death in the world, with more than one million cases occurring worldwide annually. The chance of a woman having invasive breast cancer some time during her life is about 1 in 8. The chance of dying from breast cancer is about 1 in 35. In Uganda, breast cancer is second most co ...
... second cause of cancer death in the world, with more than one million cases occurring worldwide annually. The chance of a woman having invasive breast cancer some time during her life is about 1 in 8. The chance of dying from breast cancer is about 1 in 35. In Uganda, breast cancer is second most co ...
non-surgical breast biopsy frequently asked questions
... experience. During this time it is important to remember that most breast biopsies turn out to be benign (non-cancerous). The nurse will call to inform you of the results of the biopsy as soon as the results are received from the pathology department. This usually takes two to four business days aft ...
... experience. During this time it is important to remember that most breast biopsies turn out to be benign (non-cancerous). The nurse will call to inform you of the results of the biopsy as soon as the results are received from the pathology department. This usually takes two to four business days aft ...
Men get breast cancer too - Breast Cancer Network Australia
... the cancer. The most common type of surgery for men with breast cancer is a mastectomy, where the whole breast (including the nipple and area around the nipple) is removed. Breast conserving surgery (also called lumpectomy, partial mastectomy or wide local excision), where only the part of the breas ...
... the cancer. The most common type of surgery for men with breast cancer is a mastectomy, where the whole breast (including the nipple and area around the nipple) is removed. Breast conserving surgery (also called lumpectomy, partial mastectomy or wide local excision), where only the part of the breas ...
Non-Invasive Devices for Early Detection of Breast Tissue
... and treatment are the keys to surviving breast cancer. Breast cancer survival rates vary greatly worldwide, ranging from over 80% in North America, Sweden and Japan to around 60% in middle-income countries and below 40% in low-income countries. It is believed that the low survival rates in less deve ...
... and treatment are the keys to surviving breast cancer. Breast cancer survival rates vary greatly worldwide, ranging from over 80% in North America, Sweden and Japan to around 60% in middle-income countries and below 40% in low-income countries. It is believed that the low survival rates in less deve ...
special article - Annals of Oncology
... intensity and type of treatment. There is a tendency to withhold therapy in some elderly patients because of fear of toxicity or concern about co-morbidity. In some cases, however, such therapies may be highly effective and could improve both survival and quality of life. At the same time, younger p ...
... intensity and type of treatment. There is a tendency to withhold therapy in some elderly patients because of fear of toxicity or concern about co-morbidity. In some cases, however, such therapies may be highly effective and could improve both survival and quality of life. At the same time, younger p ...
Genetic Testing for Susceptibility to Breast and Ovarian Cancer
... While the vast majority of breast cancer cases do not demonstrate strong familial tendencies, it has been reported that 5–10% are due to inherited forms of the disease, with similar rates reported for ovarian cancer (NCI, 2013a). Several genes associated with the predisposition to breast and ovarian ...
... While the vast majority of breast cancer cases do not demonstrate strong familial tendencies, it has been reported that 5–10% are due to inherited forms of the disease, with similar rates reported for ovarian cancer (NCI, 2013a). Several genes associated with the predisposition to breast and ovarian ...
Recent treatment advances in HER2-positive metastatic breast cancer
... also include inhibition of transcription of p27 (a Cdk2 inhibitor). Trastuzumab increases nuclear and cytosolic levels of p27, thereby leading to cell cycle arrest (cytostatic effect) [5,7] . Trastuzumab has not only cytostatic but also cytotoxic properties. At least in part, these two properties ma ...
... also include inhibition of transcription of p27 (a Cdk2 inhibitor). Trastuzumab increases nuclear and cytosolic levels of p27, thereby leading to cell cycle arrest (cytostatic effect) [5,7] . Trastuzumab has not only cytostatic but also cytotoxic properties. At least in part, these two properties ma ...
Breast Reconstruction with Tissue Expander
... following mastectomy or at a later time. The best candidates, however, are women whose breast cancer, as far as can be determined, seems to be eliminated by mastectomy and other treatments. Breast reconstruction has no known effect on altering the natural history of breast cancer or interfering with ...
... following mastectomy or at a later time. The best candidates, however, are women whose breast cancer, as far as can be determined, seems to be eliminated by mastectomy and other treatments. Breast reconstruction has no known effect on altering the natural history of breast cancer or interfering with ...
Congenital and Developmental Abnormalities of
... normal response levels have also been hypothesized [17–19]. These finding suggest premature thelarche may be an incomplete form of precocious puberty. Phenotypically, girls may also demonstrate accelerated growth and bone age, but are otherwise medically and sexually normal. Premature thelarche may ...
... normal response levels have also been hypothesized [17–19]. These finding suggest premature thelarche may be an incomplete form of precocious puberty. Phenotypically, girls may also demonstrate accelerated growth and bone age, but are otherwise medically and sexually normal. Premature thelarche may ...
Risk factors for breast cancer
Risk factors for breast cancer may be divided into preventable and non-preventable. Their study belongs in the field of epidemiology. Breast cancer, like other forms of cancer, can result from multiple environmental and hereditary risk factors. The term ""environmental"", as used by cancer researchers, means any risk factor that is not genetically inherited. For breast cancer, the list of environmental risk factors includes the individual person's development, exposure to microbes, ""medical interventions, dietary exposures to nutrients, energy and toxicants, ionizing radiation, and chemicals from industrial and agricultural processes and from consumer products...reproductive choices, energy balance, adult weight gain, body fatness, voluntary and involuntary physical activity, medical care, exposure to tobacco smoke and alcohol, and occupational exposures, including shift work"" as well as ""metabolic and physiologic processes that modify the body's internal environment."" Some of these environmental factors are part of the physical environment, while others (such as diet and number of pregnancies) are primarily part of the social, cultural, or economic environment.Although many epidemiological risk factors have been identified, the cause of any individual breast cancer is most often unknowable. Epidemiological research informs the patterns of breast cancer incidence across certain populations, but not in a given individual. Approximately 5% of new breast cancers are attributable to hereditary syndromes, and well-established risk factors accounts for approximately 30% of cases.